Sean Bohen - Sep 27, 2021 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: PRESIDENT AND CEO, Director
Signature: /s/ John B. Moriarty, Jr., Attorney-in-Fact
Stock symbol: OLMA
Transactions as of: Sep 27, 2021
Transactions value $: -$27,392
Form type: 4
Date filed: 9/29/2021, 07:56 PM
Previous filing: Sep 9, 2021
Next filing: Oct 15, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OLMA	Common Stock	Options Exercise	$5.23K	+1.09K	+2.07%	$4.82	53.6K	Sep 27, 2021	Direct
transaction	OLMA	Common Stock	Sale	-$32.6K	-1.09K	-2.02%	$30.07	52.5K	Sep 27, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise	$0	-1.09K	-0.11%	$0.00	971K	Sep 27, 2021	Common Stock	1.09K	$4.82	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F2	(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable.

Content

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.

(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable.